Amparo Villablanca is a Cardiology physician affiliated with University of California, Davis. OpenAlex indexes 100 publications with 2,436 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4860 Y St
Suite 2820
Sacramento, CA 958172307
Telephone
916-734-3764Registry record last updated 11 Sept 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AngioDynamics, Inc.Program year20251 payment
- ShockWave Medical, IncProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.9%Beta blocker16.4%Metoprolol Tartrate52%Metoprolol Succinate28%Carvedilol20%Part D≥35 patientsStatin15%Atorvastatin Calcium59%Rosuvastatin Calcium41%Part D≥36 patients+ 12 more classes in this area
Blood & clotting
8.1%Factor Xa inhibitor7.2%Eliquis88%Xarelto12%Part D<11 patientsP2Y12 inhibitor0.9%Clopidogrel100%Part D<11 patientsMetabolism & gastrointestinal
5.1%SGLT2 inhibitor2.6%Jardiance100%Part D≥11 patientsPotassium supplement2.4%Potassium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 1999–2018 per NIH RePORTER. The latest:
- Role of lipid droplets in neurovascular inflammation
University of California at Davis
FY2018$385,071R01AG045541 - Role of lipid droplets in neurovascular inflammation
University of California at Davis
FY2017$390,220R01AG045541 - Role of lipid droplets in neurovascular inflammation
University of California at Davis
FY2016$390,117R01AG045541
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Single nuclei transcriptomics in diabetic mice reveals altered brain hippocampal endothelial cell function, permeability, and behavior
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
2023 - Relationship Between Age at Menopause, Obesity, and Incident Heart Failure: The Atherosclerosis Risk in Communities Study
Journal of the American Heart Association
2022 - A high sucrose diet modifies brain oxylipins in a sex-dependent manner
Prostaglandins Leukotrienes and Essential Fatty Acids
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Ezra Amsterdam, MD
University of California, Davis
Michael Rogawski, MD
University of California, Davis
Christopher Bowlus, MD
University of California, Davis
Emanual Maverakis, MD
University of California, Davis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”